Skip to main content

MoneyWorks4Me

With no major difference for the quarter endedMarch 2025 , the total revenue stood at Rs. 123.24  millions.The Net Loss for the quarter ended March 2025 is Rs. -33.93 millions as compared to Net Profit of Rs. 5.42 millions of corresponding quarter ended March 2024The company reported a good operating profit of 11.39 millions compared to 10.85 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 123.24 122.07 0.96 501.95 479.75 4.63 501.95 479.75 4.63
Other Income 0.87 0.82 6.10 3.08 3.21 -4.05 3.08 3.21 -4.05
PBIDT 11.39 10.85 4.98 41.90 15.89 163.69 41.90 15.89 163.69
Interest 0.69 1.48 -53.38 4.15 6.76 -38.61 4.15 6.76 -38.61
PBDT 10.70 9.37 14.19 37.75 9.13 313.47 37.75 9.13 313.47
Depreciation 1.03 0.94 9.57 3.85 3.68 4.62 3.85 3.68 4.62
PBT 9.67 8.43 14.71 33.90 5.45 522.02 33.90 5.45 522.02
TAX 43.60 3.01 1348.50 43.69 3.01 1351.50 43.69 3.01 1351.50
Deferred Tax 7.79 3.01 158.80 7.88 3.01 161.79 7.88 3.01 161.79
PAT -33.93 5.42 -726.01 -9.79 2.44 -501.23 -9.79 2.44 -501.23
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) 9.24 8.89 3.98 8.35 3.31 152.03 8.35 3.31 152.03
Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..